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ABSTRACT 
Molecular docking is a computational technique which predicts the binding energy and the preferred binding 
mode of a ligand to a protein target. Virtual screening is a tool which uses docking to investigate large chemical 
libraries to identify ligands that bind favorably to a protein target. We have developed a novel scoring based 
distributed protein docking application to improve enrichment in virtual screening. The application addresses 
the issue of time and cost of screening in contrast to conventional systematic parallel virtual screening methods 
in two ways. Firstly, it automates the process of creating and launching multiple independent dockings on a high 
performance computing cluster. Secondly, it uses a Nȧive Bayes scoring function to calculate binding energy of 
un-docked ligands to identify and preferentially dock (Autodock predicted) better binders. The application was 
tested on four proteins using a library of 10,573 ligands. In all the experiments, (i). 200 of the 1,000 best binders 
are identified after docking only ~14 percent of the chemical library, (ii). 9 or 10 best-binders are identified after 
docking only ~19 percent of the chemical library, and (iii). no significant enrichment is observed after docking 
~70 percent of the chemical library. The results show significant increase in enrichment of potential drug leads in 
early rounds of virtual screening. 
SECTION 1, INTRODUCTION 
Modern drug discovery is a “lengthy, expensive, difficult, and inefficient process” with low rate of new 
therapeutic discovery [1]. Currently, the research and development cost of each new molecular entity is 
approximately US $1.8 billion [2]. Conventional experimental procedures such as medicinal chemistry and high 
throughput screening (HTS) are still the most accurate methods for rapid identification of drug leads. However, 
there is an enormous growth in commercial and publicly available chemical structure libraries of potential drug 
compounds (ligands), such as the ZINC database [3], [4] (contains over 21 million compounds), which require 
more efficient techniques for screening. In this context, computational methods are now being used to enhance 
the drug development process [5] , [6]. 
 
Molecular docking is a computational technique which predicts the interaction between a protein and a 
potential drug compound [7], [8], [9]. Virtual screening, the use of high-performance computing (HPC) clusters 
to analyze large databases of ligands, is a well established and cost-effective method for identifying possible 
drug leads against a target protein [10], [11] , [12], [13]. Virtual screening utilizes docking to simulate protein-
ligand interaction to prioritize potential ligands for experimental validation. There exist standard docking 
protocols like DOCK [14], AutoDock [15], [16], GOLD [17] and FlexX [18] which predict if a ligand is a good binder 
and a potential drug lead for a given target protein. 
 
Independent nature of these docking simulations allows for implementation of distributed protein docking, 
where a feasible number of these docking processes can be run simultaneously on a computing cluster. 
Currently, there a variety of software, including Docking@Home [19], DOVIS [20] and DockFlow [21], which 
automate the parallelization of virtual screening process to scale large chemical libraries. However, the selection 
of aforementioned N ligands is systematic or pre-defined in nature. Consequently, the entire chemical library 
needs to be docked in order to find the best binders which is time consuming for large chemical libraries. 
 
To further reduce the time and cost of virtual screening, parallelization can be implemented using a mechanism 
to select potential binders from the remaining chemical library based on the docking results and the chemical 
nature of previously docked ligands. This set of potential binders needs a thoughtfully compiled sample of 
ligands for screening. These potential binders can then be queued for the docking process, preferentially over 
the others. Such an implementation eliminates the necessity of docking all the ligands in a chemical library, 
thereby, optimizing the virtual screening process. 
 
The pharmaceutical industry heavily relies on Christopher Lipinski’s rule-of-five analysis for assessing if a 
compound is likely to be bioavailable [22], [23]. The rule establishes that certain compound properties (viz. 
molecular weight, lipophilicity, number of hydrogen bond donors and acceptors), if below threshold values, are 
highly correlated with a drugs having good bioavailability [24]. These properties are familiar to and routinely 
calculated by pharmaceutical researchers. We have, in our previous work, shown the utility of Lipinski properties 
as attributes in a neural net-based prediction of binding affinity, with an accuracy of 86 percent [25]. We, 
therefore, propose the use of Lipinski properties of ligands as attributes in a scoring function to predict the 
binding energy of un-docked ligands much more quickly than via full Autodock calculations, which are not viable 
for large datasets like ZINC. 
 
In this article, we present an application which performs supervised learning using binding energy of previously 
docked ligands and their similarity with un-docked ligands in terms of their Lipinski properties in a Nȧıv̇e Bayes 
analysis, to make a prediction of binding energy of un-docked ligands. We present the performance of this 
application on four receptor proteins using an in-house library of 10,573 ligands which we have used in our 
previous docking studies [25], [26]. 
SECTION 2. METHODS 
2.1 Setup 
2.1.1 System Architecture 
The application was originally developed and deployed on Marquette University’s P e`re Cluster. The cluster is 
composed of 128 nodes, 2 × quad core Intel Xeon 𝑋𝑋5550, total of 1,024 cores. The processors feature 24 GB 
RAM per node, DDR Inifiband backbone, 20 Gb/s, Red Hat Enterprise Linux 5.3. 
 
2.1.2 Tools and Software 
The scoring based virtual screening application was developed using several tools, modules, and a docking 
software. A list of all these resources is as follows: 
 
HTCondor. It is a resource management and scheduling system for executing computation-intensive jobs 
harnessing idle compute power [27], [28], [29]. The Directed Acyclic Graph Manager (DAGMan) is a meta-
scheduler for HTCondor jobs [30]. It is specially designed to provide a scheduling mechanism for jobs which have 
a dependency on each other. A DAGMan serves as a very handy tool in managing jobs that are components of a 
large workflow. In this work, HTCondor 7.4.4 for X86_64-LINUX_RHEL5 is used a resource scheduler. 
 
AutoDock. It is a widely used open source software for protein docking, which predicts how ligands bind to the 
pre-calculated docking area (grid) on the target protein [15] .These grids aid the physical description of the 
docking site and binding [16] . Lower predicted binding energy implies better ligand affinity. In this work, all 
dockings were performed using Autodock4. 
 
MGLTools. The proteins and ligands used in this work were processed and using the MGLTools [31]. 
 
Python. Python 2.4.3 was used as the programming language for code development [32]. 
 
2.2 Implementation 
The HTCondor DAGMan is used to implement incremental docking using an X-DAG structure as shown in Fig. 1a. 
With this kind of dependency, jobs B, C, D will not start until job A is completed; job E will not start until jobs B, 
C, and D are completed and so on. Fig. 1b shows the submission file for such a DAG. Each job is defined by the 
keyword JOB and the relationship between jobs is defined by recursive usage of keywords PARENTand CHILD 
[33]. Each CHILD job in the X-DAG represents a ligand-protein docking simulation and each PARENT job 
represents the execution of the scoring function.  
 
 Fig. 1.  
Implementation of X-Dag architecture: (a). The X-DAG workflow: Jobs B, C, D are launched when job A is 
completed. Job E is launched when jobs B, C, D are completed and so on, (b). A sample HTCondor DAGMan input 
file for a X-DAG. Each job is defined by the keyword JOB, jobs at the nodes are defined by the of keyword 
PARENT, and jobs at the leaves are defined by the keyword CHILD, illustrating the dependence relationship. 
Fig. 2 shows the basic framework of our scoring based virtual screening application. The functionality can be 
broken down into three distinct steps: 
1. Data partitioning. The application takes as input a data file (.tar format) which consists of the pre-
prepared ligands, proteins and the supporting files in a ready to dock format. A dag submission file is 
created which contains the job definitions for determining the order in which the ligands are docked by 
the HTCondor worker nodes. Nligands are selected randomly for the first round of dockings to initiate 
the cycle. 
2. Job submission and control. The result of each round of docking is sent back to HTCondor’s central 
manager. At the end of each round of docking (i.e., at points A, E, I in Fig. 1a and so on) the scoring 
function predicts the next N best binders, which are then dynamically updated in the dag file and 
docked in the next round. This process is continued K times such that all the ligands are docked. Fig. 3 
shows the implementation of the scoring function. 
3. Aggregation of results. Once all the ligands from the given chemical library have been docked and 
results are obtained by the central manager, the last step in the X-DAG is a summarize step 
implemented in by HTCondor’s post script. In this step, the ligands are sorted on the basis of their 
Autodock predicted binding energy and the final output file is created. This step is useful in deciding 
how many rounds of docking are essential to discriminate the potential binders from non-binders. 
 Fig. 2.  
System architecture: Workflow of the scoring based distributed docking application. Multiple docking jobs are 
created and the dockings are implemented in an incremental fashion. The set of ligands for each round of 
docking is determined by the scoring function. 
 
 
Fig. 3.  
Implementation of Nȧıv̇e Bayes scoring function. Nligands are selected randomly for docking in round 1. The 
results of docking and the Lipinski properties of ligands are used to make a selection of the ligands to be docked 
in the next cycle. K rounds of docking are performed such that all the ligands in the library are docked for 
performance evaluation of the system. 
 
2.3 Naıv̇e Bayes Scoring Function 
Lipinski’s Rule-of-Five establishes the importance of four different physico-chemical properties which are 
correlated with a chemical compound having good bioavailability viz. Molecular Weight, AlogP, Number of 
Hydrogen Acceptors and Number of Hydrogen Donors [22]. The expected Autodock predicted binding energy of 
a ligand is calculated based on the calculated binding energy of docked ligands and the Lipinski properties of 
ligands as attributes in a Nȧıv̇e Bayes analysis. 
 
Each Lipinski property is grouped into ten equal sized bins based on the range of values of each property. For 
example, if the molecular weight of the ligands in the chemical library varies between 80 and 99 Daltons (range 
= 20), then the bins would be 80-81, 82-83, and so on up to 98-99. Each ligand in the chemical library is assigned 
to a bin for each property. So a ligand, L, can be represented as a vector of four property bins corresponding to 
each Lipinski property, 𝑙𝑙𝑖𝑖 (i = 1-4). 
 
Similarly, binding energy is grouped into five equal sized bins based on the range of binding energy values for 
the Nligands docked in each round. Each docked ligand is then assigned to one of the five energy bins, 𝐸𝐸𝑘𝑘 (k = 1-
5). This information along with the ligand property is then used to find the probability of an un-docked ligand (L) 
having binding energy in each of the five bins. The probability of a ligand having a binding energy can be 
calculated using the Bayes theorem:  
 
𝑃𝑃(𝐸𝐸𝑘𝑘|𝐿𝐿) = 𝑃𝑃(𝐿𝐿|𝐸𝐸𝑘𝑘)𝑃𝑃(𝐸𝐸𝑘𝑘)𝑃𝑃(𝐿𝐿) ,  (1) 
 
where, 𝑃𝑃(𝐸𝐸𝑘𝑘|𝐿𝐿) is the probability that the ligand will have a binding energy in bin 𝐸𝐸𝑘𝑘, 𝑃𝑃(𝐿𝐿|𝐸𝐸𝑘𝑘) is the probability 
of an energy bin given a ligand 𝑃𝑃(𝐸𝐸𝑘𝑘) is the probability of any energy bin, and 𝑃𝑃(𝐿𝐿) is the probability of 
occurrence of any ligand. Assuming that each ligand is equally likely to occur in a chemical library, 𝑃𝑃(𝐿𝐿) is 
assigned a constant value. Also, 𝑃𝑃(𝐸𝐸) is the ratio of the number of ligands in each energy bin and the number of 
ligands docked so far (𝑁𝑁), which is a constant. So, 𝑃𝑃(𝐿𝐿|𝐸𝐸𝑘𝑘) can be re-written as:  
 
𝑃𝑃(𝐿𝐿|𝐸𝐸𝑘𝑘) = 𝜋𝜋𝑖𝑖=14 𝑃𝑃𝐿𝐿(𝑙𝑙𝑑𝑑𝑖𝑖|𝐸𝐸𝑘𝑘).  (2) 
 
Making the Nȧıv̇e assumptions of independence of ligand properties and representing the Lipinski bins for the 
docked ligands as 𝑙𝑙𝑑𝑑𝑖𝑖(𝑖𝑖 = 1 − 4),𝑃𝑃(𝐿𝐿|𝐸𝐸𝑘𝑘) can be written as a product of 𝑃𝑃𝐿𝐿(𝑙𝑙𝑑𝑑𝑖𝑖|𝐸𝐸𝑘𝑘), which is the probability of 
a ligand having a Lipinski property 𝑙𝑙𝑑𝑑𝑖𝑖  if it had a binding energy in energy bin 𝐸𝐸𝑘𝑘:  
 
𝑃𝑃(𝐿𝐿|𝐸𝐸𝑘𝑘) = 𝜋𝜋𝑖𝑖=14 𝑃𝑃𝐿𝐿(𝑙𝑙𝑑𝑑𝑖𝑖|𝐸𝐸𝑘𝑘).  (3) 
 
𝑃𝑃𝐿𝐿(𝑙𝑙𝑑𝑑𝑖𝑖|𝐸𝐸𝑘𝑘) is the ratio of number of un-docked ligands with the same Lipinski property bin as the docked ligands 
with an energy bin 𝐸𝐸𝑘𝑘  and the total number of ligands with an energy bin 𝐸𝐸𝑘𝑘:  
 
𝑃𝑃𝐿𝐿(𝑙𝑙𝑑𝑑𝑖𝑖|𝐸𝐸𝑘𝑘) = 𝑁𝑁(𝑙𝑙𝑑𝑑𝑖𝑖=𝑙𝑙𝑖𝑖,𝐸𝐸𝑘𝑘)𝑁𝑁𝐸𝐸𝑘𝑘 .  (4) 
 
If the number of ligands docked or the number of ligands in an energy bin is zero, the above probabilities are 
calculated by introducing a smoothing factor 𝜆𝜆 = 0.1 such that the new probabilities are:  
 
𝑃𝑃𝐿𝐿(𝑙𝑙𝑑𝑑𝑖𝑖|𝐸𝐸𝑘𝑘) = 𝑁𝑁(𝑙𝑙𝑑𝑑𝑖𝑖=𝑙𝑙𝑖𝑖,𝐸𝐸𝑘𝑘)+𝜆𝜆𝑁𝑁𝐸𝐸𝑘𝑘+4𝜆𝜆 ,  (5) 
 
𝑃𝑃(𝐸𝐸𝑘𝑘) = 𝑁𝑁𝐸𝐸𝑘𝑘+𝜆𝜆𝑁𝑁+4𝜆𝜆 .  (6) 
 
Finally, the energy bin with the highest probability is the predicted binding energy (𝐸𝐸𝐿𝐿) for each un-docked 
ligand:  
 
𝐸𝐸𝐿𝐿 = arg 𝑚𝑚𝑚𝑚𝑚𝑚
𝐸𝐸𝑘𝑘
𝑃𝑃(𝐸𝐸𝑘𝑘|𝐿𝐿)..  (7) 
 
Similarly, binding energy bins for all the un-docked ligands are estimated. N ligands with the lowest predicted 
energies are then selected for docking in the next round. 
 
2.4 Datasets 
Proteins. Four experiments on three distinct proteins were performed to evaluate the performance of 
application. The first set of proteins is Dihydrofolate Reductase (DHFR) [PDB:1DF7] and Dihydrodipicolinate 
reductase (DHPR) [PDB:1C3V] which are targets for the disease Tuberculosis [33], [34]. The other protein drug 
target is Human Dual Specificity Phosphatase 5 (DUSP5), an enzyme in humans encoded by the DUSP5 gene [35], 
[36]. DUSP5 protein has two domains and each of these domains participate in ligand binding. For this study, 
each of these domains were tested individually and are referred to as DUSP5C [PDB:2G6Z] and DUSP5R. The 
protein structure for DUSP5R was based on a homology model for a related mitogen-activated protein kinase 
phosphatase, MDP-3. The crystal structure of the proteins was obtained from the Protein Data Bank [37]. The 
details are included in the supplemental file 2, which can be found on the Computer Society Digital Library at 
http://doi.ieeecomputersociety.org/10.1109/TCBB.2015.2401020. 
 
Chemical library. An in-house physical collection of 10,573 chemical ligands in the Center for Structure-based 
Drug Design and Development (CSD3) was used [25], [26], [38]. The library contains drug-like molecules, 
selected on the basis of their predicted binding to dehydrogenases and kinases, a general compliance with the 
Lipinski Rule of Five, and other drug-like filters. The ligands were converted into a ready-to-dock format using 
Autodock tools [39]. The applicability and performance on of this chemical library has been demonstrated in our 
previous docking studies [25], [26]. The steps for the preparation of the files for the experiment are provided in 
supplemental file 1, available online. 
 
2.5 Performance Metrics 
Autodock computes the possible interaction points in the binding site of the protein and then docks each ligand 
to a protein target allowing the ligand to adopt many different conformations or poses. The docking simulation 
output consists of clusters of similar poses and the calculated binding energy for each docking pose within each 
cluster. For our experiments, we choose the cluster with the highest number of poses and then select the pose 
with the lowest predicted energy as the most favorable pose. The binding energy of this pose is used as the final 
predicted binding energy for a particular protein-ligand complex and is defined as the binding energy of the 
ligand. Lower binding energy of a protein-ligand complex is an indication of its binding affinity; lower the binding 
energy more stable the complex. 
 
The objective of introducing the scoring function in the HPC framework is to enable the identification of better 
binders allowing for enrichment in early rounds of docking. To evaluate the performance of the application all 
the ligands were docked against the target proteins and 1,000 best binding ligands were identified for each 
protein based on their binding energy. Since the predictions are not binary in nature (i.e., a strong binder and 
not a strong binder), we do not measure performance in terms of ROC and AUC. We rank the ligands based on 
their predicted binded energy and measure the performance of the algorithm in terms of simpler and more 
commonly used metrics: average energy, ligand enrichment and cumulative ligand enrichment. Average energy 
is the average binding energy (as described above) of all the ligands docked in a round, ligand enrichment is the 
concentration of ligands with low binding energies in each round compared to their concentration throughout 
the docking cycle, and cumulative ligand enrichment is the concentration of ligands with low binding energies up 
to each round compared to their concentration throughout the docking cycle [9], [40], [41], [42]. We have 
evaluated the performance of the application based on enrichment observed for the 1,000 best binders in each 
round of incremental docking and is calculated as:  
 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝑚𝑚𝐴𝐴𝐴𝐴𝐸𝐸𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 = ∑𝐸𝐸𝑖𝑖
𝑁𝑁𝑅𝑅
,  (8) 
𝐿𝐿𝑖𝑖𝐴𝐴𝑚𝑚𝐴𝐴𝑑𝑑𝐸𝐸𝐴𝐴𝐴𝐴𝑖𝑖𝐿𝐿ℎ𝑚𝑚𝐴𝐴𝐴𝐴𝑚𝑚 = 𝑁𝑁𝑅𝑅1,000,,  (9) 
𝐶𝐶𝐶𝐶𝑚𝑚𝐶𝐶𝑙𝑙𝑚𝑚𝑚𝑚𝑖𝑖𝐴𝐴𝐴𝐴𝐿𝐿𝑖𝑖𝐴𝐴𝑚𝑚𝐴𝐴𝑑𝑑𝐸𝐸𝐴𝐴𝐴𝐴𝑖𝑖𝐿𝐿ℎ𝑚𝑚𝐴𝐴𝐴𝐴𝑚𝑚 = 𝑁𝑁𝑇𝑇1,000,,  (10) 
 
where, 𝐸𝐸𝑖𝑖  is the binding energy of the ith ligand docked in a round, 𝑁𝑁𝑅𝑅 is the number of ligands docked in a 
round, 𝑁𝑁𝑅𝑅1,000 is the number of best 1,000 binders docked in a round and 𝑁𝑁𝑇𝑇1,000 is number of 1,000 best 
binders docked so far. 
 
SECTION 3. RESULTS 500 ligands were docked in each round of incremental docking with a total of 22 rounds. If the ligands docked in 
each round were to be selected in a random fashion, it would be expected that each round is enriched with 50 
out of 1,000 best binding ligands. 
 
Fig. 4 shows the plot between the average energy of all ligands docked in a round versus round number. 
Average energy decreased substantially after the very first round of Bayesian selection of potential binders. For 
all four proteins (i). average energy in round 2 is the lowest across all rounds. (ii). average energy starts to 
increase after an initial decrease and attains a value higher than in round 1 towards the end of virtual screening 
experiments. These results demonstrate the earlier rounds are enriched with lower binding energy ligands 
(better binders) and later rounds have lesser number of potential binders. 
 
 
Fig. 4.  
Plot between average binding energy of a round and round number. Lower binding energy indicates better 
protein-ligand complexes. Rounds 2 and 3 show a significant drop in average energy for all four proteins 
indicating significant enrichment in better binding ligands. 
 
To verify that the binding actually occurs in the naturally occurring binding site, a visual representation of the 
protein-ligand complex is generated using Pymol [43]. Fig. 5 shows the predicted docking complex of the four 
proteins with the ligand with lowest binding energy (best binder) in the second round of docking. During docking 
preparation, co-crystallized ligands were removed from the PDB coordinates allowing ligands to occupy the 
known binding sites. It is observed that the ligand (represented by stick model) is strategically placed in the 
natural substrate binding site of the protein molecules and as seen in the inset images. For DHFR and DHPR, the 
predicted inhibitors were predicted to bind in the NADP+ pocket for each enzyme (see Supplemental Fig. 1, 
available online). The predicted inhibitor for DUSP5C was predicted to bind adjacent to the known active 
nucleophile for the protein, Cys-263 (see Supplemental Fig. 2). This structure is structurally similar to a group of 
molecules recently published [44]. As DUSP5R is based on a homology model, further investigation to probe the 
binding site of this regulatory domain is required. 
 
 
Fig. 5.  
Focused image of the protein-ligand complex at the binding site. The inset shows full image of the protein-ligand 
complex. 
 
Figs. 6a and 6b show ligand enrichment and cumulative ligand enrichment for each round, respectively. A sharp 
spike at rounds 2 and 3 in the ligand enrichment plot shows the effectiveness of the scoring function in 
identifying potential binders. The steep slope of the curve in the cumulative ligand enrichment plot between 
rounds 2 and 3 is an indicative of higher rate of enrichment in earlier rounds. For all proteins, (i). 200 of 1,000 
best binding ligands are identified by docking only 14 percent of the chemical library, (ii). 500 of 1,000 best 
binding ligands are identified by docking only 28 percent of the chemical library, (iii). there is no significant gain 
in enrichment after docking almost 70 percent of the chemical library, and (iv). nine or 10 best binding ligands 
are identified within docking 19 percent of the chemical library. 
 
 
Fig. 6.  
Enrichment observed in terms of the 1,000 best binders in each round of incremental docking. 
 
In all the four experiments, 1,000 best binders were docked in rounds 2 and 3 with p-value < 0.001. The results 
suggest that virtual screening for any protein can be considered complete after round 5 by docking only 30 
percent of the chemical library. These results demonstrate that our approach has a selective preference for 
better binding ligands and provides better enrichment as compared to a completely random parallel virtual 
screening application. Additionally, it offers time and cost benefits by reducing the need to dock the entire 
chemical library to identify potential Autodock predicted drug leads. 
SECTION 4. CONCLUSION 
Virtual screening is a computational method to identify potential drug leads from a large chemical library. Ligand 
enrichment, thus, forms the essence of virtual screening. High performance computing clusters strengthen the 
capabilities of virtual screening process by further gain in time and cost. However, the growing size of available 
chemical libraries and the aspiration for exhaustive search for a potential drug from the entire virtual chemical 
pool necessitates a new methodology to allow for faster discrimination of binders from the non-binders. 
 
We present an optimization to the virtual screening workflow allowing for large throughput of results in smaller 
time scale. We have implemented a Nȧıv̇e Bayes scoring function which performs supervised learning using 
Lipinski properties and binding energy of ligands for a given target protein to predict the binding energy of 
unknown ligands. The application harnesses HTCondor’s capability as a resource management system to 
automatically schedule parallel and distributed protein dockings. The results of using this application to isolate 
binders for four target proteins suggest that potential drug leads can be isolated by examining not more than 
30 percent chemicals in a large chemical, saving the need to investigate the entire chemical library. 
 
The application is compatible with and can be deployed on different computing clusters with slight or no 
modification. We have tested the performance of the application after porting and integration with other 
available grids like BOINC [45] and TeraGrid [46] . The application can also be implemented on a commercial 
cloud. We have successfully migrated it to the Amazon EC2 cloud to assess the feasibility of such an 
implementation. A detailed performance analysis and comparison was also done to validate against local high 
performance computing resources. It was found that the application can be implemented on the cloud as there 
is no overhead required to set up an in-house cluster or grid, software requirements are inexpensive or free, and 
computing time is rapid based on the number of resources purchased on the cloud. 
 
However, the performance of this framework at the level of ZINC is still to be tested. It remains to be seen that 
enrichment and scaling obtained in this study can be maintained at the size of ZINC. Nonetheless, the early 
results are promising and further investigations to see if this approach scales appropriation are needed. 
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SUPPLEMENTARY MATERIALS 
Supplement 1: Steps for preparation of input files 
1. STEPS FOR PREPARING THE LIGAND MOLECULE 
(i) Load the ligand into the viewer (Ligand > Input> Open Ligand.pdb). 
(ii) Determine which atom fits its idea of the best root (Ligand > Torsion Tree > Detect Root). 
(iii) Determine which rotatable bonds to be active (Ligand > Torsion Tree > Choose Torsions). 
(iv) Set the numbers of bonds to be active (Ligand > Torsion Tree > Set Number of Torsions). 
(v) Save the prepared Ligand (Ligand > Output > Save as Ligand.pdbqt). 
(vi) Remove from viewer (Edit > Delete Molecule). 
 
2. STEPS FOR PREPARING THE PROTEIN MOLECULE 
(i) Edit Protein 
a. Open the Protein structure file (File > Read Molecule .pdb). 
b. Color atoms by chemical element (Color > By Atom Type > All Geometries ¿ OK). 
c. Add Polar Hydrogen Atoms, choose default (Edit > Hydrogens > Add > Select All Hydrogens, no Bond 
Order, yes > OK). 
d. Save the Macromolecule (File > Save > Write PDB). 
e. Delete all molecules. 
(ii) Prepare Macromolecule File 
a. Add the charges and solvation parameters, choose defaults (Grid > Macromolecule > Open .pdb file 
saved in saved in 1.e). 
b. Save the file (Save as .pdbqt file). 
(iii) Prepare the Grid Parameter File 
a. Specify the type of Maps used, Add A, Br, C, Cl, F, H, HD, I , N, NA, OA, P, SA, S (Grid > Set Map Types > 
Open Ligand). 
b. Select the grid for Docking (Grid > Grid Box > Choose to center on ligand or atom, Make the grid box 
bigger to encapsulate the entire ligand > Delete Molecule > Close saving current). 
c. Save the Grid Parameter File (Grid > Output > Save GPF). 
d. Start Autogrid4 in the directory where .gpf file is located (autogrid4 p grid.gpf l grid.glg &). 
e. Delete Molecule from ADT. 
(iv) Prepare Docking Parameter File (dpf): This step is to be done for all the ligands in the ligand library. In this 
work, this step is scripted to prepare the dpf file for all ligands at once. 
a. Open the edited Macromolecule (Docking > Macromolecule > Set Rigid Filename). 
b. Select the current Ligand (Docking > Ligand > Choose Ligand). 
c. Select Docking Algorithm, choose 50-100 GA Runs (Docking > Search Parameters > Genetic Algorithm). 
d. Select Default docking parameters (Docking > Docking Parameters).  
e. Choose the Algorithm (Docking > Output > Lamarckian GA). 
f. Save as .dpf 
 
3. COMBINING THE INPUT DATA TO CREATE THE INPUT TAR FILE 
(i) Copy all the prepared ligands and the protein in one directory. 
(ii) Prepare the dpf file for all the ligands by scripting step 4 in protein preparation. 
(iii) Copy all the map files to be used for docking.  
(iv) Tar the directory. 
(v) Repeat these steps for all the proteins used. 
 
Supplement 2: Protein Structure and Supplemental Figures 
1 Protein structure source 
DHFR with NADP bound: http://www.rcsb.org/pdb/explore/explore.do?structureId=1df7 
DHPR with NADP bound: http://www.rcsb.org/pdb/explore/explore.do?structureId=1C3V 
DUSP5C: http://www.rcsb.org/pdb/explore/explore.do?structureId=2g6z 
DUSP5R: Homology model based on 1HZM (25 
 
Website link last assessed: 10/14/2014 
 
2 Supplemental Figures 
 
 
(a) Co-crystallized DHFR with natural ligand NDP+ 
 
 
(b) DHFR with natural ligand and superimposed docked ligand 
 
 
(c) Co-crystallized DHPR with natural ligand NDP+  
 
 
(d) DHPR with natural ligand and superimposed docked ligand 
 
Figure 1: Natural co-crystallized ligands and the overlayed image of the best docked ligand in round 2 
of incremental docking. 
 
 
 
Figure 2: Natural co-crystallized DUSP5C-nucleophile complex 
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